Windows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallOutdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchNo single test diagnoses dementia. A clinician reaches a diagnosis by combining a history of change, its effect on everyday activities, cognitive assessment, physical and mental-health evaluation, and selected blood, urine, imaging, or biomarker tests. Each test answers a narrower question: Is cognition changing? Could another condition explain it? Is there structural brain damage? Is Alzheimer’s-related amyloid biology present?
That distinction matters. Dementia is a clinical syndrome involving cognitive decline that interferes with daily life. Alzheimer’s disease is one possible cause, alongside vascular disease, Lewy body disease, frontotemporal disorders and other conditions. A test may support one part of the picture without identifying the cause or proving that a person has dementia.
As an Amazon Associate I earn from qualifying purchases.
Screening, diagnostic workup and biomarker testing are related but different. Screening is a brief check for possible concern; a diagnostic workup explains the pattern and its effect on function; a biomarker test measures a particular biological feature. Understanding which of these you are being offered makes the result easier to interpret.
Free tools Windows power users keep installed
One-click scans. No signup required.
What doctors mean by a dementia diagnosis
Diagnosis starts with a pattern, not a number. The clinician looks for a decline from the person’s previous abilities and asks whether the change affects tasks such as managing medicines, paying bills, cooking, driving, communicating or navigating familiar places. Someone can score below an age-based average yet function independently; another person can score within a broad normal range while struggling noticeably in real life.
#1 Best Overall
- Read Before You Buy — No Video Output: These adapters support charging and USB 2.0 data transfer, but cannot transmit video signals. Except for standard USB webcams (which use USB data only), they are not compatible with HDMI/DisplayPort cables, video-capable USB-C hubs, or docking stations with video output.
- Convert USB-A Ports to USB-C: Designed to connect USB-C earphones, cables, flash drives, card readers, and other USB-C accessories to standard USB-A ports. Plug-and-play with no drivers or software required.
- Aluminum Alloy Housing: Built with a sturdy aluminum alloy shell that aids in heat dissipation and protects against daily wear and scratches. Designed to maintain a stable and secure connection.
- Compact & Travel-Friendly: The ultra-compact design allows the adapter to stay plugged into your device without blocking adjacent ports or adding bulk, reducing wear and tear on your original USB ports.
- 12-Month Warranty: Backed by a 12-month manufacturer warranty for peace of mind. Designed to meet strict quality control standards for reliable everyday performance.
The NHS summarizes the principle plainly: “There’s no single test for dementia.” A cognitive score, scan or blood result therefore cannot stand alone. Results are interpreted alongside the person’s history, examination, medicines, other illnesses, mood, sleep, hearing and vision.
Clinicians also consider the time course. A sudden change may point toward an acute illness, medication effect, seizure, stroke or another urgent problem rather than a slowly progressive neurodegenerative disorder. Gradual change, stepwise decline after strokes, prominent fluctuations, movement symptoms, language-led problems or early changes in social behavior can each steer the evaluation toward different possibilities. These patterns are clues, not self-diagnoses.
What happens during an assessment
The exact sequence varies by country, clinic and symptoms. Possible components described by the NHS and the US National Institute on Aging (NIA) include:
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Repair Windows errors before they cause bigger problems3Scan for outdated or missing drivers - takes under a minute- History of symptoms: when the changes began, whether they are gradual or sudden, and which abilities have changed.
- Daily-function review: what the person can still do independently and where help is now needed.
- Medication and health review: prescription drugs, over-the-counter products, supplements, alcohol or other substances, and conditions that can affect thinking.
- Collateral history: observations from a relative, friend or other person who knows the patient well.
- Cognitive assessment: brief tasks covering memory, attention, language, orientation, counting or problem-solving.
- Physical and neurological examination: signs that suggest stroke, movement disorder, sensory loss or another neurological cause.
- Laboratory testing: blood and sometimes urine tests for reversible or contributing conditions.
- Brain imaging or specialist tests: CT, MRI and, in selected cases, PET, SPECT, EEG, cerebrospinal-fluid analysis or blood biomarkers.
Primary-care clinicians may refer to a geriatrician, geriatric psychiatrist, neurologist or neuropsychologist. Referral does not imply that every test will be ordered; investigations are selected according to the history and examination.
The NIA describes a broad Alzheimer’s evaluation that can include health and medication history, review of activities and behavior, tests of memory, problem-solving, attention, counting and language, standard laboratory testing, psychiatric evaluation, cerebrospinal-fluid analysis and brain imaging. These are possible components rather than a mandatory checklist. A specialist may order more detailed neuropsychological testing when a short office screen cannot explain the person’s difficulties, while another patient may need only a focused examination and basic laboratory work.
Cognitive tests: useful signal, not a verdict
Brief cognitive tools sample abilities such as short- and long-term memory, attention, language, orientation and problem-solving. The General Practitioner Assessment of Cognition (GPCOG) is one tool used in UK general practice, but clinics use several alternatives and local pathways differ.
What a cognitive test can show
- Whether performance raises enough concern to justify fuller assessment.
- Which domains—memory, language, attention or executive function—need closer examination.
- A baseline against which future change might be compared.
- Whether a person can follow instructions, retain information briefly, retrieve words or organize a simple task under test conditions.
What it cannot show by itself
- It cannot establish dementia without evidence of decline and effects on daily life.
- It cannot identify the underlying disease with certainty.
- It cannot rule out a problem simply because the score is high.
- It cannot predict exactly how someone will manage complex, real-world tasks such as finances or medication organization.
Education can influence scores. The NHS cautions that a lower score does not automatically mean dementia and a high score does not necessarily exclude it. Anxiety, fatigue, pain, depression, hearing or vision problems, language and cultural factors can also affect performance. A result should therefore be explained in context rather than treated as a pass-or-fail exam.
Ask which test was used, whether norms appropriate to the person’s age, education and language were considered, and which domains were weak. Repeating a test too soon can be affected by familiarity with the questions, while a meaningful baseline can help clinicians judge change over time. A brief screen is not equivalent to formal neuropsychological assessment, which may take substantially longer and examine a broader range of abilities.
Blood and urine tests: looking for other explanations
Routine laboratory work is generally not a universal “dementia blood test.” Its purpose is to find illnesses that can mimic cognitive decline, worsen it or be treated. NHS examples include liver and kidney function, thyroid function, HbA1c for diabetes, and vitamin B12 and folate. Urine or other tests may be added when infection is suspected.
A normal panel does not prove that cognition is healthy, and an abnormal result does not prove dementia. It may instead identify a separate problem that needs treatment or a contributor that should be corrected before cognitive performance is reassessed. The clinician may also review whether medicines or combinations of medicines could be affecting alertness, balance or memory.
Rank #2
- 5-in-1 USB-C Hub: Experience comprehensive connectivity featuring a Power Delivery input, two USB-A 2.0 ports, a USB-A 3.0 port, and an HDMI port. (Note: The USB-C power delivery input port is only for connecting an external wall charger to power your laptop and cannot power peripheral devices.)
- 90W Pass-Through Charging: Achieve optimal charging with 90W pass-through power to your laptop, supported by a total input of 100W, with the hub reserving 10W for operational efficiency. (Note: Wall charger not included.)
- Quick Data Transfers: Accelerate your productivity with rapid data transfers using a high-speed 5Gbps USB 3.0 port and two 480Mbps USB 2.0 ports.
- 4K HDMI Display: Enhance your visual experience with a hub capable of delivering 4K resolution at 30Hz in both mirror and extend modes. Please note that this hub is compatible with MacBook (macOS 12 and newer), Windows 10 and 11, ChromeOS, and laptops equipped with DP Alt Mode and Power Delivery. Note: This device is not compatible with Linux.
- What You Get: Anker USB-C Hub (5-in-1, 4K HDMI), welcome guide, 18-month warranty, and our friendly customer service.
Laboratory testing is therefore a “what else could be happening?” step. It is useful even when the eventual diagnosis is a neurodegenerative disease, because treating a thyroid disorder, vitamin deficiency, diabetes problem or infection can improve symptoms or prevent further deterioration. The precise panel and timing depend on symptoms, medical history and local practice.
CT and MRI: structure, injury and alternative causes
Computed tomography (CT) and magnetic resonance imaging (MRI) show brain structure. They can support the workup by identifying atrophy patterns, vascular damage, prior strokes, bleeding, hydrocephalus, a tumour or another structural explanation for symptoms.
MRI generally provides more detailed structural information than CT. The NHS notes that MRI can provide information relevant to dementia type and vascular injury, while CT can identify some problems with less structural detail. The NIA also lists CT and MRI as tools that may support an Alzheimer’s evaluation or investigate alternatives.
Imaging has an important limit: a scan that looks normal or does not show obvious changes does not rule out dementia. Early disease, small changes, technical factors and differences between individuals can make structural findings subtle. The scan is one piece of evidence, not a stand-alone diagnosis.
A radiology report may describe age-related changes, white-matter disease or atrophy without determining whether those findings explain the person’s symptoms. The treating clinician must connect the images with the timeline, examination and functional history. Conversely, a scan can reveal an urgent alternative cause even when the cognitive symptoms seem typical of dementia.
The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →When specialists consider PET, SPECT, EEG or spinal-fluid testing
PET and SPECT
Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) can show selected aspects of brain function or protein deposition. The NHS says PET or SPECT may be considered when CT or MRI findings are uncertain, and that most people will not need these scans. Their usefulness depends on the clinical question, the tracer or protocol, and local specialist access.
These scans are not interchangeable. A particular PET protocol may examine metabolism or amyloid, while SPECT can provide information about patterns of blood flow. The clinician should explain what the requested tracer is intended to show and what decision the result could change.
EEG
An electroencephalogram (EEG) records electrical brain activity. It is uncommon in a routine dementia assessment but may be considered when a specialist suspects epilepsy or another condition that produces episodic confusion.
Cerebrospinal fluid
Cerebrospinal fluid (CSF) is collected by lumbar puncture. NIA materials describe CSF analysis as a way to measure biological features associated with Alzheimer’s disease and related dementias. A CSF result still needs clinical interpretation; it does not replace the history, examination or functional assessment.
Because lumbar puncture is invasive, the expected benefit and alternatives should be discussed. A CSF biomarker can answer a focused question about Alzheimer’s-related biology, but it does not by itself explain every symptom or identify every possible dementia cause.
Rank #3
- Sleek 7-in-1 USB-C Hub: Features an HDMI port, two USB-A 3.0 ports, and a USB-C data port, each providing 5Gbps transfer speeds. It also includes a USB-C PD input port for charging up to 100W and dual SD and TF card slots, all in a compact design.
- Flawless 4K@60Hz Video with HDMI: Delivers exceptional clarity and smoothness with its 4K@60Hz HDMI port, making it ideal for high-definition presentations and entertainment. (Note: Only the HDMI port supports video projection; the USB-C port is for data transfer only.)
- Double Up on Efficiency: The two USB-A 3.0 ports and a USB-C port support a fast 5Gbps data rate, significantly boosting your transfer speeds and improving productivity.
- Fast and Reliable 85W Charging: Offers high-capacity, speedy charging for laptops up to 85W, so you spend less time tethered to an outlet and more time being productive.
- What You Get: Anker USB-C Hub (7-in-1), welcome guide, 18-month warranty, and our friendly customer service.
Alzheimer’s biomarkers answer a narrower question
Biomarker tests look for biological evidence associated with Alzheimer’s disease, especially amyloid plaques and tau-related changes. They do not diagnose every form of dementia, and amyloid can be present without proving that it is the reason for a person’s symptoms.
Think of a biomarker as evidence about a mechanism, not a complete clinical label. A clinician still needs to establish that there is cognitive impairment, determine whether it affects daily life, consider other illnesses and decide whether Alzheimer’s biology plausibly accounts for the presentation. A result can be useful for clarifying an uncertain diagnosis, but it should not be interpreted in isolation or used as a consumer screening shortcut.
FDA-cleared plasma ratio test
On May 16, 2025, the US Food and Drug Administration (FDA) announced clearance of Fujirebio’s Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio. It is an aid for detecting Alzheimer’s-associated amyloid plaques in symptomatic adults aged 55 and older. The FDA says it is intended for specialized care, not as a general home screen, and that results must be interpreted with other clinical information. False-positive and false-negative results are possible.
In the study reported in that announcement, 91.7% of people with a positive Lumipulse result had amyloid plaques on the PET or CSF comparison, while 97.3% of people with a negative result also had a negative PET or CSF comparison. Fewer than 20% of the 499 tested patients had an indeterminate result. Those figures describe that assay, comparator and symptomatic study population; they are not a guarantee of identical performance for every patient, laboratory or commercial test.
The comparator matters. The study compared the blood result with amyloid PET or CSF findings, not with a universal definition of dementia. A positive result therefore means the test agreed with evidence of amyloid plaques in that study context; it does not mean every person with that result has Alzheimer’s dementia, nor does a negative result exclude vascular, Lewy body, frontotemporal or other disorders.
Specialty-care guideline thresholds
The Alzheimer’s Association’s 2025 specialty-care guideline says blood biomarkers meeting at least 90% sensitivity and 75% specificity can be used for triage. Tests meeting at least 90% sensitivity and specificity may substitute for amyloid PET or CSF biomarker testing in cognitively impaired patients presenting to specialist memory care. These thresholds apply to the guideline’s defined population and setting; they do not qualify every marketed blood test.
Sensitivity describes how often a test is positive when the target biology is present; specificity describes how often it is negative when that biology is absent. Neither number alone tells you the chance that a particular person’s result is correct. That chance also depends on the tested population, the laboratory method and the clinical reason for testing.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Additional 2026 assay update
Roche announced on August 24, 2026, that the FDA had cleared its Elecsys pTau217 assay as an aid in identifying amyloid pathology in adults aged 55 and older with signs, symptoms or complaints of cognitive decline. Roche said results should be interpreted with clinical information. The FDA device-classification description likewise defines this category as an aid for symptomatic patients rather than a complete dementia diagnosis. Availability, reimbursement and regulatory status can differ outside the United States.
How the main test categories differ
| Test category | Main question | Typical role | Setting and invasiveness | Important limits |
|---|---|---|---|---|
| Cognitive assessment | Which thinking abilities appear impaired? | Screening or structured support for further evaluation | Usually an office test; noninvasive | Scores are affected by education, language, mood, sensory problems and context; it does not identify cause alone. |
| Blood and urine tests | Could another illness or treatable contributor explain the symptoms? | Routine investigation | Blood draw and, when indicated, urine sample | A normal panel does not exclude dementia; an abnormal result may point to a different condition. |
| CT | Is there a structural problem such as stroke, bleeding or tumour? | Supportive imaging and investigation of alternatives | Noninvasive scan, often available urgently | Less structural detail than MRI; normal findings do not rule out dementia. |
| MRI | What structural changes or vascular injury are present? | Supportive imaging and assessment of alternatives | Noninvasive, but takes longer and may be difficult for people with claustrophobia or some implanted devices | Findings require clinical interpretation and may be subtle or absent early. |
| PET or SPECT | Is there a specific functional or molecular pattern when routine imaging is uncertain? | Selected specialist cases | Specialist imaging with a tracer; access varies | Most people do not need them; access and usefulness depend on the clinical question. |
| EEG | Could abnormal electrical activity, such as epilepsy, explain episodes? | Uncommon, targeted specialist test | Noninvasive recording of electrical activity | Not a routine dementia test. |
| CSF or blood Alzheimer’s biomarker | Is Alzheimer’s-associated biology likely to be present? | Specialist diagnostic aid or triage in defined populations | Blood draw or lumbar puncture, depending on the method | Does not diagnose all dementias or replace clinical assessment; false results are possible. |
These categories should not be ranked by one “accuracy” number. They answer different questions, involve different levels of invasiveness and are studied in different populations. The most informative test is the one that addresses the uncertainty identified in the clinical assessment.
Genetic tests are about risk, not a dementia diagnosis
Genetic testing can identify variants associated with increased or decreased risk of some diseases. A risk-related variant does not prove that a person currently has dementia, and not carrying one does not rule it out. Genetic results can have implications for relatives and may require specialist counselling before and after testing.
Rank #4
- Dual Converters, Infinite Potential：Includes 2× USB C male to USB A female adapters and 2× USB A male to USB C female adapters. Perfect for a wide range of uses—tablets with Bluetooth keyboards, expand USB ports on macbook, and more. Two different converters for all your daily needs
- Next-Level 10Gbps & 3A Charging: No more slow 480Mbps, this usb to usb c adapter has a transfer speed of up to 10Gbps, allowing you to do more transferring in less time. This usb adapter fits both USB A and USB C charger, supporting up to 3A fast charging
- Upgraded Exquisite Craftsmanship: With an aluminum alloy housing and metal connector, the usbc to usb adapter is extremely durable and sturdy. Rigorously tested to withstand more than 10,000 times of plugging and unplugging, ensuring long-lasting performance
- Broad Compatible: The usb c to usb adapter widely supports all USB C/ USB A devices like laptops, tablets, cellphones, car chargers, and phone chargers. Such as compatible with MacBook Pro/Air 2023/2022, Thunderbolt 4/3 Devices,Apple MagSafe Watch 9/8/7/SE/Ultra, iPad Pro 2022/2021, Samsung Galaxy S23/S20/S10, and iPhone 17/16/15 Pro. Plug and play
- Please Note: To reach 10Gbps speed, keep the cable under 3.3 ft. For USB A Male to USB C adapters, try flipping the USB C connector. USB C Male to USB A adapters support bidirectional 10Gbps transfer within 3.3 ft
Ask what the test is designed to detect: a rare disease-causing mutation, a risk-associated variant or something else. The answer affects how strongly the result can be used in clinical decision-making. Genetic testing should not be confused with an Alzheimer’s biomarker test that measures current disease-associated biology.
Recommended Free Tools
How to prepare for the appointment
A concise, concrete history often helps more than trying to remember every detail in the consultation. Bring:
- A timeline: approximate dates of the first changes, whether they progressed gradually, and any sudden episodes.
- Everyday examples: missed bills, repeated questions, getting lost, medication errors, difficulty cooking, altered judgment or changes in communication.
- A complete medication list: prescriptions, non-prescription medicines, vitamins, supplements and alternative products, including doses if known.
- Relevant health information: recent illnesses, falls, strokes, sleep problems, depression, hearing or vision changes and alcohol use.
- A companion, if the patient wants one: someone who has observed the changes can add details the patient may not notice or remember.
A notebook or caregiver log is an optional organizational aid. It is not a diagnostic device, and no particular product is required. The log can record dates, examples and questions, but it should not be used to make a diagnosis or replace an appointment.
It is also reasonable to ask in advance which tests are being considered, whether fasting or medication changes are required, how results will be communicated and who will explain them. Costs, insurance coverage and availability vary by health system; the clinic or insurer is the appropriate source for local information.
How to interpret a result and decide what happens next
If a cognitive score is lower than expected
Ask which abilities were affected, how education and language were considered, and what follow-up will clarify whether the change affects daily function. A low score is a reason to investigate, not a diagnosis by itself.
If blood or urine tests are abnormal
Ask whether the finding could explain or worsen the symptoms, what treatment is recommended, and whether cognition should be reassessed after the condition is addressed.
If imaging shows changes
Ask which finding is clinically meaningful, whether it suggests vascular disease or another cause, and how it fits the symptom timeline. Structural changes can support a diagnosis without proving one specific disease.
If an Alzheimer’s biomarker is positive or negative
Ask what population and assay the result applies to, whether the result is indeterminate, and how it changes the clinician’s diagnosis or treatment plan. A positive amyloid-related result does not establish that Alzheimer’s is the only cause of symptoms; a negative result does not answer every possible dementia question.
If no single test gives a clear answer
Ask what uncertainty remains and what observation, repeat assessment or specialist review could resolve it. Some diagnoses become clearer as the symptom pattern evolves. A planned follow-up can be more informative than ordering every available test immediately.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Situations that need prompt medical attention
Progressive memory difficulty is usually assessed through a planned appointment. Sudden confusion, new weakness, trouble speaking, a severe new headache, loss of consciousness or rapidly worsening symptoms can signal an emergency such as stroke, infection, bleeding or a medication reaction and should be assessed urgently.
Best Value
- 5-in-1 Connectivity: Equipped with a 4K HDMI port, a 5 Gbps USB-C data port, two 5 Gbps USB-A ports, and a USB C 100W PD-IN port. Note: The USB C 100W PD-IN port supports only charging and does not support data transfer devices such as headphones or speakers.
- Powerful Pass-Through Charging: Supports up to 85W pass-through charging so you can power up your laptop while you use the hub. Note: Pass-through charging requires a charger (not included). Note: To achieve full power for iPad, we recommend using a 45W wall charger.
- Transfer Files in Seconds: Move files to and from your laptop at speeds of up to 5 Gbps via the USB-C and USB-A data ports. Note: The USB C 5Gbps Data port does not support video output.
- HD Display: Connect to the HDMI port to stream or mirror content to an external monitor in resolutions of up to 4K@30Hz. Note: The USB-C ports do not support video output.
- What You Get: Anker 332 USB-C Hub (5-in-1), welcome guide, our worry-free 18-month warranty, and friendly customer service.
Frequently asked questions
What tests are used to diagnose dementia?
Clinicians combine a history of change, daily-function review, cognitive assessment, physical and neurological examination, medication review and selected blood, urine, imaging or specialist tests. There is no single required sequence and no stand-alone dementia test.
Can a normal MRI rule out dementia?
No. MRI can show vascular injury, structural problems and patterns that support a diagnosis, but early or subtle disease may not be obvious. The scan must be interpreted with symptoms and function.
Does a low memory-test score mean I have dementia?
No. Education, language, mood, fatigue, pain, hearing and vision can affect performance. Dementia requires evidence of decline that interferes with everyday life, not merely a low score.
Free tools Windows power users keep installed
One-click scans. No signup required.
What does a positive Alzheimer’s blood test mean?
For an appropriately cleared assay used in the indicated symptomatic population, it may indicate Alzheimer’s-associated amyloid biology. It does not by itself prove Alzheimer’s dementia, identify every cause of symptoms or replace clinical assessment.
Are home dementia test kits reliable?
The FDA-cleared plasma ratio described here is intended for specialized care, not general home screening. Consumer tests and cognitive games should not be treated as diagnostic substitutes. Discuss any result with a qualified clinician.
How should I prepare for testing?
Bring a symptom timeline, concrete examples of daily changes, a complete medication and supplement list, relevant health information and, if the patient agrees, someone who has observed the changes.
Frequently Asked Questions
What tests are used to diagnose dementia?
Clinicians combine history, daily-function review, cognitive assessment, examination, medication review and selected laboratory, imaging or specialist tests. No single test is required for everyone or proves dementia by itself.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Can a normal MRI rule out dementia?
No. MRI can reveal structural or vascular changes and alternative causes, but early or subtle dementia may have no obvious imaging abnormality.
Does a low cognitive-test score mean dementia?
No. Education, language, mood, fatigue, pain, hearing and vision affect scores. Diagnosis also requires evidence of decline and interference with daily life.
What does a positive Alzheimer’s blood biomarker mean?
It may indicate Alzheimer’s-associated amyloid biology in the population and assay for which it was cleared. It does not by itself establish Alzheimer’s dementia or rule out other causes.
Are home dementia test kits a substitute for assessment?
No. The FDA-cleared plasma ratio described here is intended for specialized care, not general home screening. Consumer tests and games should not replace clinical evaluation.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
How can I prepare for an appointment?
Bring a timeline, concrete examples of daily changes, a complete medication and supplement list, relevant health information and a companion who has observed changes if the patient agrees.
The Bottom Line
Dementia diagnosis is a clinical judgment built from history, daily function, cognitive testing and targeted investigations. Cognitive scores flag concerns; blood and urine tests look for treatable contributors; CT and MRI show structure and alternatives; PET, SPECT, EEG and CSF answer selected specialist questions; and Alzheimer’s biomarkers detect narrower biological features. Ask what question each test addresses, what its limitations are and how the result will change the care plan.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
